NeuroOne CEO Dave Rosa talks uplisting on Nasdaq, upcoming advancements

NeuroOne commercialized its first diagnostic brain-scan product in January and uplisted to the Nasdaq in May.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.